Rifaximin

XIFAXAN

Rifamycin Antibacterial

NADAC/unit N/A

No Shortage Tier 1: 26.4% PA Req: 142.9%

To reduce the development of drug-resistant bacteria and maintain the effectiveness of XIFAXAN and other antibacterial drugs, XIFAXAN when used to treat infection should be used only to treat or pr....

Covered Lives

Generic Manufacturers

SALIX PHARMACEUTICALS INC

Explore in the Ecosystem

rxsaver.aiCompare prices for Rifaximin drfinder.aiFind doctors who prescribe Rifaximin rxbenefits.aiEmployer cost impact analysis clinicalrx.aiClinical profile: Rifaximin

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.